Targeting Multi-Chain Digital Asset Growth and Decentralized Finance (DeFi) Integration SARASOTA, FL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO), today announced the launch of a cryptocurrency treasury strategy which is expected to focus on leading digital assets, including Bitcoin, Ethereum, and Solana. The Company intends to make opportunistic purchases of digital currencies following launch and to leverage staking to generate yield while also focusing on capital preservation and t ...

Financial Data and Key Metrics Changes - Total revenues in Q1 2025 were $8.8 million, down approximately 44% compared to Q1 2024 [15] - Operating expenses in Q1 2025 were $39.9 million, compared to $8.9 million in Q1 2024, including a $29.8 million contingency reserve related to a DOJ settlement [15] - The net loss for Q1 2025 was $64.7 million, or $6.74 per share, compared to a net income of $6.1 million, or $0.88 per share in Q1 2024 [18] Business Line Data and Key Metrics Changes - The healthcare business is experiencing pressure from payment changes made by CMS, impacting revenue [12] - The company is targeting growth in the cardiovascular space and plans to introduce additional FDA cleared products [12][25] Market Data and Key Metrics Changes - The company has acquired a total of 3,808 Bitcoins valued at approximately $400 million, making it the fourth largest Bitcoin treasury company in the US [6] - In 2025, the company acquired 1,510 Bitcoins with a BTC yield of 22.2%, resulting in a BTC dollar gain of $52 million [6] Company Strategy and Development Direction - The company prioritizes its Bitcoin treasury strategy while managing its healthcare business to generate cash for Bitcoin purchases [10] - The strategic focus includes diversifying the customer base and innovating in the healthcare sector [12][25] Management's Comments on Operating Environment and Future Outlook - Management acknowledges headwinds in the healthcare business but sees potential for growth through new initiatives [12] - The company aims to minimize declines in QuantiFlo revenue while expanding into new markets [25] Other Important Information - The company launched a Bitcoin dashboard for investors to track Bitcoin-related statistics [21] - A new $500 million ATM program became effective on April 22, 2025, to support Bitcoin acquisitions [8] Q&A Session Summary Question: What are your plans this year for accumulating more Bitcoin? - The company has ambitious plans to increase its Bitcoin stockpile and is confident in utilizing its $500 million ATM for additional acquisitions [23] Question: What's driving the underlying trends in the business, and what do you expect for 2025? - Despite government payment changes, the company continues to see testing and customer additions, focusing on maintaining infrastructure for growth in cardiovascular disease states [24][25]

Financial Data and Key Metrics Changes - Total revenues in Q1 2025 were $8.8 million, down approximately 44% compared to Q1 2024 [13] - Operating expenses in Q1 2025 were $39.9 million, compared to $8.9 million in Q1 2024, including a $29.8 million contingency reserve related to a DOJ settlement [13] - The net loss for Q1 2025 was $64.7 million, or $6.74 per share, compared to a net income of $6.1 million, or $0.88 per share in Q1 2024 [15] Business Line Data and Key Metrics Changes - The healthcare business is experiencing pressure from payment changes made by CMS, but there are signs of growth in diversifying the customer base and introducing new FDA cleared products [11] - The company is pursuing a new 510(k) clearance for a product extension aimed at diagnosing heart failure, expected in 2025 [11] Market Data and Key Metrics Changes - The company has acquired a total of 3,808 Bitcoins valued at nearly $400 million, making it the fourth largest Bitcoin treasury company in the U.S. [6] - In 2025, the company acquired 1,510 Bitcoins with a yield of 22.2%, resulting in a BTC dollar gain of $52 million [6] Company Strategy and Development Direction - The corporate strategy is focused on three core principles: prioritizing the Bitcoin treasury strategy, ensuring the healthcare business generates cash, and increasing Bitcoin holdings [9] - The company aims to manage its healthcare business to generate cash primarily for Bitcoin purchases [4] Management's Comments on Operating Environment and Future Outlook - Management acknowledges headwinds in the healthcare business but remains optimistic about future growth opportunities in the cardiovascular space [11] - The company emphasizes its commitment to executing its Bitcoin treasury strategy alongside its healthcare business [24] Other Important Information - The company completed a $100 million convertible note financing round, using most proceeds to buy Bitcoin [7] - A new $500 million ATM program became effective on April 22, 2025, to support further Bitcoin acquisitions [7] Q&A Session Summary Question: What are your plans this year for accumulating more Bitcoin? - The company has ambitious plans to increase its Bitcoin stockpile and is confident in utilizing its $500 million ATM for additional acquisitions [21] Question: What's driving the underlying trends in the business, and what do you expect for 2025? - Despite government payment adjustments, the company is focused on minimizing declines in QuantiFlo revenue while expanding its customer base and targeting new markets [22][23]